Efficacy of a two-dose hepatitis B vaccination with a novel immunostimulatory sequence adjuvant (Heplisav-B) on patients with chronic liver disease: a retrospective study
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.